ArticleEFSA journal. European Food Safety Authority2026
Statement on MRLs for difluoroacetic acid (DFA).
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to carry out a targeted review of the maximum residue levels (MRLs) for difluoroacetic acid (DFA), following the availability of data on DFA residue levels in commodities for which EU MRLs are based on Codex MRLs. EFSA identified the Codex MRLs implemented into EU legislation that may affect the corresponding MRLs for DFA and perform consumer risk assessment using current residue definitions and the health-based guidance values, applying the latest version of the pesticide residues intake model (PRIMo) model (revision 3.1). Based on the data available, EFSA derived MRL proposals for DFA in the relevant commodities. The exposure calculations performed by EFSA showed that the proposed MRLs do not result in consumer intake concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.